On immunity against infections and vaccines: credo 2004.
about
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestationsConservation and variability of dengue virus proteins: implications for vaccine designImpact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOTTo drive or be driven: the path of a mouse model of recurrent pregnancy lossA systematic bioinformatics approach for selection of epitope-based vaccine targetsSpatiotemporal Dynamics of Virus Infection Spreading in TissuesA commentary on the Zinkernagel-Hengartner 'Credo 2004'.Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.On the opposing views of the self-nonself discrimination by the immune system.The evolutionary context for a self-nonself discriminationCD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolutionAmphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.On the responses of Zinkernagel and Hengartner: an invitation to join the frayTime, space and contextual models of the immunity tolerance decision: bridging the geographical divide of Zinkernagel and Hengartner's 'Credo 2004'.Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral controlThe potential role of fowlpox virus in rational vaccine design.Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.T cell-dependent and -independent IgA responses: role of TLR signalling.Correlates of protection induced by vaccination.Immunological memory ≠ protective immunity.Targeting lentiviral vectors for cancer immunotherapy.A global "imaging'' view on systems approaches in immunology.The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence.Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based MediumInduction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag cChurg-Strauss syndrome presenting as scar reactivation: histopathologic features and an illustration of 'locus minoris resistentiae'.Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy.On observing and analyzing disease versus signals.Local immunoglobulin production in nasal polyposis is modulated by superantigens.The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.
P2860
Q21195408-242BFD35-A7F6-4BE5-9F10-8235230E9244Q24288762-3E1EDB3B-3186-49BA-ACE2-075364A1DBA6Q24815388-F95F0190-19FC-4922-A05B-919834DBB379Q26866038-4ED6A027-1CE2-402D-800C-5ADB7B328502Q27481378-ED9BBB10-D227-49C7-90A7-01904B0277E1Q28354089-FDBDB532-E804-49C6-997F-C472A60CEF3CQ28768605-BD46B4C5-E2FD-4ECB-8F7B-23B4C33B4D6DQ30427484-8514F6F5-4B30-4CE9-B695-FDED080DAC83Q33894534-7C211527-7E20-4B97-806E-155147489A60Q34207060-A50A6495-303A-458F-BBF1-4528F154C1FEQ35121645-CBE4D80E-1BE5-4CD4-AFF2-E838757791B3Q35887551-C0FB1E0F-6D28-45D2-AB3D-8FC688819A5BQ36223589-559AD469-C0FA-4E21-95A5-614840A6F753Q36453422-F230C1CC-B769-46B5-92E8-11B96415C552Q36501145-0529BF63-FA73-4419-A721-9A52114A07CEQ36600376-86A44482-3AA8-41AD-86BD-351530588FC0Q37194029-F9519C43-2505-4C92-B4B7-61F203CA72EBQ37744904-21BF295B-1345-492F-93B8-7382E0C65EBDQ37750121-DB4A1879-CE72-4335-A6EB-866FCCB555F0Q38000488-A867C8D7-BB7F-4528-B1D3-1119CB0FF800Q38043924-366617A8-A869-4F3B-887B-6951A9D0889FQ38068788-80237F5A-7876-4D00-B33E-32B8BEFF14C5Q38206518-49393DFF-3740-4AF3-A1FF-E4CF3C10214EQ38544409-3384231C-B0B6-4B65-82AD-3D60A846D1FEQ39028785-628296E4-A584-496F-8664-D77AC7853DD0Q40257246-06C19F35-DAF9-4D1A-B446-FD53C9AB5089Q42110927-7B9F4B3B-F146-4372-8804-5C16A081AC43Q45143199-D94BACE9-EE2C-4DB4-B1D9-F39D6499E04CQ49041126-0DC29815-A198-4B01-952C-D48A00DB38FFQ51978164-25F4B0AB-2717-49E7-8271-A874F1D1C724
P2860
On immunity against infections and vaccines: credo 2004.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
On immunity against infections and vaccines: credo 2004.
@ast
On immunity against infections and vaccines: credo 2004.
@en
type
label
On immunity against infections and vaccines: credo 2004.
@ast
On immunity against infections and vaccines: credo 2004.
@en
prefLabel
On immunity against infections and vaccines: credo 2004.
@ast
On immunity against infections and vaccines: credo 2004.
@en
P2860
P1476
On immunity against infections and vaccines: credo 2004.
@en
P2093
Hengartner H
Zinkernagel RM
P2860
P356
10.1111/J.0300-9475.2004.01460.X
P577
2004-07-01T00:00:00Z